WallStSmart

Accenture plc (ACN)vsCastellum Inc. (CTM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Accenture plc generates 129843% more annual revenue ($72.11B vs $55.49M). ACN leads profitability with a 10.6% profit margin vs -2.9%. ACN earns a higher WallStSmart Score of 62/100 (C+).

ACN

Buy

62

out of 100

Grade: C+

Growth: 4.7Profit: 7.0Value: 8.0Quality: 6.5
Piotroski: 3/9Altman Z: 2.79

CTM

Avoid

34

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 5.0Quality: 8.0
Piotroski: 4/9Altman Z: 1.61
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACNUndervalued (+35.3%)

Margin of Safety

+35.3%

Fair Value

$197.84

Current Price

$129.15

$68.69 discount

UndervaluedFair: $197.84Overvalued

Intrinsic value data unavailable for CTM.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACN6 strengths · Avg: 8.5/10
Market CapQuality
$101.87B9/10

Large-cap with strong market position

Return on EquityProfitability
24.5%9/10

Every $100 of equity generates 25 in profit

Debt/EquityHealth
0.269/10

Conservative balance sheet, low leverage

P/E RatioValuation
13.5x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$3.60B8/10

Generating 3.6B in free cash flow

CTM3 strengths · Avg: 8.7/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
22.5%8/10

Revenue surging 22.5% year-over-year

Areas to Watch

ACN2 concerns · Avg: 3.5/10
EPS GrowthGrowth
4.0%4/10

4.0% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

CTM4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Market CapQuality
$74.20M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-4.4%2/10

ROE of -4.4% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : ACN

The strongest argument for ACN centers on Market Cap, Return on Equity, Debt/Equity. PEG of 1.16 suggests the stock is reasonably priced for its growth.

Bull Case : CTM

The strongest argument for CTM centers on Debt/Equity, Price/Book, Revenue Growth. Revenue growth of 22.5% demonstrates continued momentum.

Bear Case : ACN

The primary concerns for ACN are EPS Growth, Piotroski F-Score.

Bear Case : CTM

The primary concerns for CTM are EPS Growth, Altman Z-Score, Market Cap.

Key Dynamics to Monitor

ACN profiles as a value stock while CTM is a growth play — different risk/reward profiles.

ACN carries more volatility with a beta of 1.07 — expect wider price swings.

CTM is growing revenue faster at 22.5% — sustainability is the question.

ACN generates stronger free cash flow (3.6B), providing more financial flexibility.

Bottom Line

ACN scores higher overall (62/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accenture plc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Accenture plc is an Irish-domiciled multinational company that provides consulting and processing services. It has been incorporated in Dublin, Ireland since 2009.

Castellum Inc.

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Castellum, Inc. provides services in the areas of cyber security, information technology, electronic warfare, information warfare, and information operations. The company is headquartered in Bethesda, Maryland.

Visit Website →

Want to dig deeper into these stocks?